EQIX
64
2
F
58
11
VFC
53
5
M
37
12
HD
57
2
CMG
72
5
LB
63
22
TROW
56
5
HCA
44
-2
EL
25
4
FSLR
54
7
HRB
57
5
UPS
60
9
INTU
56
-4
BSX
67
-3
NTAP
67
-3
ROK
62
15
HPE
63
2
EBAY
47
4
AN
58
4
EQIX
64
2
F
58
11
VFC
53
5
M
37
12
HD
57
2
CMG
72
5
LB
63
22
TROW
56
5
HCA
44
-2
EL
25
4
FSLR
54
7
HRB
57
5
UPS
60
9
INTU
56
-4
BSX
67
-3
NTAP
67
-3
ROK
62
15
HPE
63
2
EBAY
47
4
AN
58
4
Financhill
Back

Immunovant Vs. Perspective Therapeutics Industry Stock Comparison

Buy
57

IMVT
Immunovant

Last Price:
26.88
Seasonality Move:
2.57%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
57
Immunovant (IMVT) is a Buy

Is Immunovant a Buy, Sell or Hold?

  • The current Immunovant [IMVT] share price is $26.87. The Score for IMVT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IMVT Stock Price Chart

What is Immunovant's stock price today?

  • The Immunovant share price today is $26.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

IMVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.93 Sell
Relative Strength Index (14 RSI): 40.93 Sell
Chaikin Money Flow: 176564 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.24 - 30.72) Sell
Bollinger Bands (100): (27.84 - 31) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

IMVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.74 Buy
20-day SMA: 28.73 Sell
50-day SMA: 29.09 Sell
200-day SMA: 29.92 Sell
8-day EMA: 27 Sell
20-day EMA: 28.13 Sell
50-day EMA: 28.94 Sell
200-day EMA: 29.53 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Immunovant Earnings Growth & IMVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $1.15 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Immunovant Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):